Month: November 2018

The Business Cocktail

Business Consultant, DelveInsight's Drug Report, Pharma Consultant, The Business Cocktail

Preclinical biotech Synthorx needs a USD 100 Million IPO The early-stage Synthorx needs USD 100 million IPO.  A while ago, La Jolla,...

Read More

‘Invisible’ mice reveal anatomical secrets

Business Consultant, Pharma Consultant, Snippets

A new technique that makes dead mice transparent and hard like plastic is giving a cue to researchers an unprecedented view of how...

Read More

World Diabetes Day

Business Consultant, Infographics, Pharma Consultant

Caring for Diabetes involves family too. Education and awareness play the most important role in early diagnosis and management. World...

Read More

Notizia

Business Consultant, Notizia, PD-1 and PD-L1 inhibitors, Pharma Consultant

The pancreatic cancer drug of GlaxoSmithKline moves to phase 1 The experimental drug, GSK095 of GlaxoSmithKline is made to work in order...

Read More

Triple Negative Breast Cancer

Articles, Business Consultant, DelveInsight's Drug Report, Pharma Consultant

What is Triple Negative Breast Cancer? Triple Negative Breast Cancer (TNBC) is defined as a heterogeneous breast cancer phenotype where the...

Read More

The Business Cocktail

Business Consultant, Pharma Consultant, The Business Cocktail

Gordon and Betty Moore Foundation gives USD 85 Million to stop delayed, erroneous diagnostics The Gordon and Betty Moore Foundation is...

Read More

Snippet

Snippets

Read More
Close